⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for de novo myelodysplastic syndromes

Every month we try and update this database with for de novo myelodysplastic syndromes cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesNCT01175785
Accelerated Pha...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Chron...
Childhood Myelo...
Chronic Phase C...
de Novo Myelody...
Previously Trea...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Relapsing Chron...
Secondary Myelo...
umbilical cord ...
fludarabine pho...
cyclophosphamid...
ex vivo-expande...
total-body irra...
cyclosporine
mycophenolate m...
laboratory biom...
6 Months - 45 YearsNohla Therapeutics, Inc.
Bryostatin 1 in Treating Patients With Myelodysplastic SyndromeNCT00003171
Leukemia
Myelodysplastic...
bryostatin 1
18 Years - Barbara Ann Karmanos Cancer Institute
Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic SyndromeNCT00005598
Myelodysplastic...
amifostine trih...
azacitidine
18 Years - University of Michigan Rogel Cancer Center
Combination Chemotherapy in Treating Older Patients With Acute Myeloid LeukemiaNCT00003602
Leukemia
Myelodysplastic...
cytarabine
etoposide
idarubicin
mitoxantrone hy...
55 Years - National Cancer Institute (NCI)
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeNCT00445744
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Essential Throm...
Myelodysplastic...
Polycythemia Ve...
Previously Trea...
Primary Myelofi...
Recurrent Adult...
Recurrent Child...
Secondary Acute...
Secondary Myelo...
Secondary Myelo...
Untreated Adult...
Untreated Child...
cyclophosphamid...
busulfan
tacrolimus
methotrexate
cytogenetic ana...
flow cytometry
pharmacological...
pharmacogenomic...
peripheral bloo...
allogeneic hema...
- 65 YearsFred Hutchinson Cancer Center
Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic SyndromeNCT00017550
Myelodysplastic...
anti-thymocyte ...
18 Years - 120 YearsSanofi
Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaNCT00451048
Chronic Myelomo...
de Novo Myelody...
Myelodysplastic...
Secondary Myelo...
sunitinib malat...
18 Years - National Cancer Institute (NCI)
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaNCT00818649
Leukemia
Myelodysplastic...
bortezomib
vorinostat
18 Years - Masonic Cancer Center, University of Minnesota
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHDNCT00914940
Graft Versus Ho...
Leukemia
Myelodysplastic...
Fludarabine Pho...
Tacrolimus
Thiotepa
Total-Body Irra...
Magnetic Affini...
Peripheral Bloo...
Allogeneic Hema...
T Cell-Depleted...
14 Years - 55 YearsFred Hutchinson Cancer Center
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaNCT00398138
Leukemia
Lung Cancer
Malignant Mesot...
Myelodysplastic...
Primary Periton...
WT-1 analog pep...
incomplete Freu...
sargramostim
polymerase chai...
flow cytometry
immunoenzyme te...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic SyndromesNCT00398047
Leukemia
Myelodysplastic...
Azacitadine and...
- 120 YearsWake Forest University Health Sciences
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT00475150
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Secondary Acute...
Secondary Myelo...
Untreated Adult...
cediranib malea...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeNCT00004208
Myelodysplastic...
ATG + CSA
Supportive care
18 Years - Swiss Group for Clinical Cancer Research
Gemtuzumab in Treating Patients With Myelodysplastic SyndromeNCT00022321
Myelodysplastic...
gemtuzumab ozog...
18 Years - National Cancer Institute (NCI)
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyNCT00891137
Leukemia
Lymphoma
Multiple Myelom...
Plasma Cell Neo...
Myelodysplastic...
human myeloid p...
12 Years - 65 YearsCellerant Therapeutics
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic SyndromeNCT00003790
Leukemia
Myelodysplastic...
polymerase chai...
flow cytometry
- 21 YearsChildren's Oncology Group
VNP40101M and Cytarabine in Treating Patients With Hematologic MalignanciesNCT00070538
Leukemia
Myelodysplastic...
cytarabine
laromustine
18 Years - National Cancer Institute (NCI)
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesNCT00234000
Leukemia
Myelodysplastic...
arsenic trioxid...
azacitidine
18 Years - Jonsson Comprehensive Cancer Center
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic SyndromeNCT00003415
Leukemia
Myelodysplastic...
amifostine trih...
topotecan hydro...
18 Years - National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeNCT00002800
Leukemia
Myelodysplastic...
Neutropenia
filgrastim
lintuzumab
cytarabine
etoposide
idarubicin
18 Years - Memorial Sloan Kettering Cancer Center
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerNCT00003661
Graft Versus Ho...
Leukemia
Lymphoma
Myelodysplastic...
Neuroblastoma
anti-thymocyte ...
busulfan
cyclosporine
melphalan
methylprednisol...
umbilical cord ...
radiation thera...
- 54 YearsRoswell Park Cancer Institute
Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDSNCT01141725
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Myelodysplastic...
Untreated Adult...
bendamustine hy...
idarubicin
50 Years - Fred Hutchinson Cancer Center
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaNCT00398138
Leukemia
Lung Cancer
Malignant Mesot...
Myelodysplastic...
Primary Periton...
WT-1 analog pep...
incomplete Freu...
sargramostim
polymerase chai...
flow cytometry
immunoenzyme te...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaNCT01707004
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Secondary Acute...
decitabine
fludarabine pho...
busulfan
cyclophosphamid...
tacrolimus
mycophenolate m...
filgrastim
total-body irra...
allogeneic bone...
laboratory biom...
18 Years - 75 YearsUniversity of Wisconsin, Madison
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesNCT00352001
Leukemia
Myelodysplastic...
azacitidine
lenalidomide
18 Years - 120 YearsCase Comprehensive Cancer Center
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersNCT00003572
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
peripheral bloo...
mycophenolate m...
tacrolimus
allogeneic bone...
radiation thera...
18 Years - 70 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic SyndromeNCT00024050
Leukemia
Myelodysplastic...
busulfan
cyclophosphamid...
cyclosporine
methotrexate
allogeneic bone...
peripheral bloo...
- 65 YearsFred Hutchinson Cancer Center
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic DiseasesNCT00003662
Graft Versus Ho...
Leukemia
Myelodysplastic...
Thymic Carcinom...
anti-thymocyte ...
busulfan
cyclophosphamid...
cyclosporine
melphalan
methylprednisol...
umbilical cord ...
radiation thera...
- Roswell Park Cancer Institute
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHDNCT00914940
Graft Versus Ho...
Leukemia
Myelodysplastic...
Fludarabine Pho...
Tacrolimus
Thiotepa
Total-Body Irra...
Magnetic Affini...
Peripheral Bloo...
Allogeneic Hema...
T Cell-Depleted...
14 Years - 55 YearsFred Hutchinson Cancer Center
Paricalcitol in Treating Patients With Myelodysplastic SyndromeNCT00064376
Leukemia
Myelodysplastic...
paricalcitol
25 Years - 100 YearsCedars-Sinai Medical Center
Belinostat in Treating Patients With Myelodysplastic SyndromesNCT00357162
de Novo Myelody...
Previously Trea...
Secondary Myelo...
belinostat
18 Years - National Cancer Institute (NCI)
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationNCT00005641
Chronic Myelopr...
Graft Versus Ho...
Leukemia
Multiple Myelom...
Myelodysplastic...
anti-thymocyte ...
busulfan
cyclophosphamid...
cyclosporine
leucovorin calc...
methotrexate
methylprednisol...
allogeneic bone...
in vitro-treate...
radiation thera...
15 Years - 60 YearsH. Lee Moffitt Cancer Center and Research Institute
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeNCT00445744
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Essential Throm...
Myelodysplastic...
Polycythemia Ve...
Previously Trea...
Primary Myelofi...
Recurrent Adult...
Recurrent Child...
Secondary Acute...
Secondary Myelo...
Secondary Myelo...
Untreated Adult...
Untreated Child...
cyclophosphamid...
busulfan
tacrolimus
methotrexate
cytogenetic ana...
flow cytometry
pharmacological...
pharmacogenomic...
peripheral bloo...
allogeneic hema...
- 65 YearsFred Hutchinson Cancer Center
Empirical Versus Preemptive Antifungal TherapyNCT01288378
Fungal Infectio...
Leukemia
Myelodysplastic...
caspofungin ace...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaNCT00087204
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Blastic Phase C...
Chronic Myelomo...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Refractory Anem...
Relapsing Chron...
Secondary Acute...
Secondary Myelo...
becatecarin
laboratory biom...
18 Years - National Cancer Institute (NCI)
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic SyndromesNCT00997243
Leukemia
Myelodysplastic...
lintuzumab
5-azacytidine
18 Years - Ohio State University Comprehensive Cancer Center
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesNCT00454480
Leukemia
Myelodysplastic...
alemtuzumab
arsenic trioxid...
azacitidine
busulfan
clofarabine
cytarabine
daunorubicin hy...
fludarabine pho...
gemtuzumab ozog...
melphalan
tipifarnib
DNA methylation...
cytogenetic ana...
gene expression...
mutation analys...
diagnostic labo...
immunologic tec...
allogeneic hema...
nonmyeloablativ...
- National Cancer Institute (NCI)
VNP40101M and Cytarabine in Treating Patients With Hematologic MalignanciesNCT00070538
Leukemia
Myelodysplastic...
cytarabine
laromustine
18 Years - National Cancer Institute (NCI)
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaNCT00118196
Leukemia
Myelodysplastic...
arsenic trioxid...
azacitidine
18 Years - 120 YearsMedical University of South Carolina
Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerNCT00112567
Leukemia
Myelodysplastic...
fludarabine pho...
thiotepa
peripheral bloo...
radiation thera...
- 20 YearsFred Hutchinson Cancer Center
S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid LeukemiaNCT00005866
Leukemia
Myelodysplastic...
busulfan
cyclophosphamid...
cyclosporine
methotrexate
allogeneic bone...
radiation thera...
16 Years - 55 YearsSWOG Cancer Research Network
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerNCT00296023
Chronic Myelopr...
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
anti-thymocyte ...
filgrastim
therapeutic all...
busulfan
fludarabine pho...
methotrexate
tacrolimus
nonmyeloablativ...
peripheral bloo...
18 Years - 75 YearsUniversity of California, San Francisco
Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic MalignanciesNCT00356928
Leukemia
Myelodysplastic...
Cyclophosphamid...
Donor T cells
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaNCT00002926
Leukemia
Myelodysplastic...
cytarabine
etoposide
idarubicin
allogeneic bone...
peripheral bloo...
16 Years - 60 YearsNational Cancer Institute (NCI)
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaNCT00003436
Leukemia
Myelodysplastic...
amsacrine
asparaginase
cytarabine
daunorubicin hy...
etoposide
methotrexate
mitoxantrone hy...
therapeutic hyd...
allogeneic bone...
- 15 YearsNational Cancer Institute (NCI)
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerNCT00290641
Chronic Myelopr...
Leukemia
Lymphoma
Myelodysplastic...
filgrastim
graft-versus-tu...
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
umbilical cord ...
radiation thera...
- 45 YearsMasonic Cancer Center, University of Minnesota
Vaccine Therapy in Treating Patients With Myelodysplastic SyndromeNCT00003959
Leukemia
Myelodysplastic...
ras peptide can...
sargramostim
17 Years - Memorial Sloan Kettering Cancer Center
Rasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesNCT01564277
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Blastic Phase C...
Contiguous Stag...
de Novo Myelody...
Noncontiguous S...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Stage I Adult B...
Stage III Adult...
Stage IV Adult ...
Untreated Adult...
Untreated Adult...
rasburicase
allopurinol
18 Years - Roswell Park Cancer Institute
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerNCT00782379
Leukemia
Lymphoma
Myelodysplastic...
busulfan
cyclophosphamid...
fludarabine pho...
mycophenolate m...
tacrolimus
allogeneic hema...
peripheral bloo...
18 Years - 60 YearsNorthside Hospital, Inc.
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic SyndromesNCT00809575
Adult
Myelodysplastic...
questionnaire a...
fatigue assessm...
observation
quality-of-life...
18 Years - Gruppo Italiano Malattie EMatologiche dell'Adulto
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerNCT00003661
Graft Versus Ho...
Leukemia
Lymphoma
Myelodysplastic...
Neuroblastoma
anti-thymocyte ...
busulfan
cyclosporine
melphalan
methylprednisol...
umbilical cord ...
radiation thera...
- 54 YearsRoswell Park Cancer Institute
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesNCT00450983
Graft Versus Ho...
Leukemia
Myelodysplastic...
muromonab-CD3
natural killer ...
fludarabine pho...
methotrexate
thiotepa
gene expression...
flow cytometry
immunologic tec...
allogeneic hema...
in vitro-treate...
total-body irra...
- 45 YearsFred Hutchinson Cancer Center
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT00475150
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Secondary Acute...
Secondary Myelo...
Untreated Adult...
cediranib malea...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk MyelodysplasiaNCT00838240
Leukemia
Myelodysplastic...
clofarabine
cytarabine
idarubicin
18 Years - 60 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeNCT00002798
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Secondary Myelo...
Untreated Child...
asparaginase
daunorubicin hy...
fludarabine pho...
therapeutic hyd...
allogeneic bone...
3-dimensional c...
filgrastim
cytarabine
idarubicin
dexamethasone
thioguanine
etoposide
methotrexate
cyclophosphamid...
aldesleukin
busulfan
- 21 YearsNational Cancer Institute (NCI)
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaNCT00006363
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 YearsNational Cancer Institute (NCI)
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT00516828
Leukemia
Myelodysplastic...
cytarabine
60 Years - Canadian Cancer Trials Group
DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromesNCT00397579
Leukemia
Myelodysplastic...
Blastic Plasmac...
DT388IL3
18 Years - University of Texas Southwestern Medical Center
Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic SyndromeNCT00005598
Myelodysplastic...
amifostine trih...
azacitidine
18 Years - University of Michigan Rogel Cancer Center
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic CancerNCT00126477
Leukemia
Lymphoma
Myelodysplastic...
Quality of Life
cognitive asses...
management of t...
psychosocial as...
quality-of-life...
18 Years - Fred Hutchinson Cancer Center
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesNCT00352001
Leukemia
Myelodysplastic...
azacitidine
lenalidomide
18 Years - 120 YearsCase Comprehensive Cancer Center
Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic SyndromeNCT00003984
Myelodysplastic...
lintuzumab
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological MalignanciesNCT00544466
Leukemia
Myelodysplastic...
fludarabine pho...
melphalan
allogeneic hema...
intensity-modul...
7 Years - City of Hope Medical Center
Combination Chemotherapy in Treating Patients With Myelodysplastic SyndromeNCT00003827
Leukemia
Myelodysplastic...
amifostine trih...
cytarabine
topotecan hydro...
16 Years - National Cancer Institute (NCI)
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other DiseasesNCT00450450
Childhood Acute...
Childhood Acute...
Childhood Chron...
Childhood Myelo...
Chronic Phase C...
de Novo Myelody...
Juvenile Myelom...
Previously Trea...
Recurrent Child...
Secondary Myelo...
allogeneic bone...
laboratory biom...
filgrastim
- 21 YearsChildren's Oncology Group
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaNCT00087204
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Blastic Phase C...
Chronic Myelomo...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Refractory Anem...
Relapsing Chron...
Secondary Acute...
Secondary Myelo...
becatecarin
laboratory biom...
18 Years - National Cancer Institute (NCI)
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantNCT00376480
Leukemia
Myelodysplastic...
anti-thymocyte ...
peripheral bloo...
fludarabine pho...
methylprednisol...
thiotepa
allogeneic hema...
in vitro-treate...
total-body irra...
- 50 YearsDana-Farber Cancer Institute
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseNCT00295971
Congenital Ameg...
Leukemia
Myelodysplastic...
Severe Congenit...
anti-thymocyte ...
therapeutic all...
fludarabine pho...
thiotepa
allogeneic bone...
allogeneic hema...
in vitro-treate...
total-body irra...
1 Year - 17 YearsUniversity of California, San Francisco
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerNCT00295880
Myeloproliferat...
Leukemia
Lymphoma
Myelodysplastic...
umbilical cord ...
12 Years - 45 YearsMasonic Cancer Center, University of Minnesota
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT01146210
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Fanconi Anemia
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Secondary Myelo...
Untreated Child...
laboratory biom...
- 21 YearsChildren's Oncology Group
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantNCT00376480
Leukemia
Myelodysplastic...
anti-thymocyte ...
peripheral bloo...
fludarabine pho...
methylprednisol...
thiotepa
allogeneic hema...
in vitro-treate...
total-body irra...
- 50 YearsDana-Farber Cancer Institute
Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell TransplantNCT00107354
Leukemia
Myelodysplastic...
aldesleukin
therapeutic all...
therapeutic aut...
cytarabine
etoposide
mitoxantrone hy...
allogeneic bone...
peripheral bloo...
14 Years - Fred Hutchinson Cancer Center
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT00475150
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Secondary Acute...
Secondary Myelo...
Untreated Adult...
cediranib malea...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaNCT01707004
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Secondary Acute...
decitabine
fludarabine pho...
busulfan
cyclophosphamid...
tacrolimus
mycophenolate m...
filgrastim
total-body irra...
allogeneic bone...
laboratory biom...
18 Years - 75 YearsUniversity of Wisconsin, Madison
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk MyelodysplasiaNCT00838240
Leukemia
Myelodysplastic...
clofarabine
cytarabine
idarubicin
18 Years - 60 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantNCT00725062
Graft Versus Ho...
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
CD4+CD25+ regul...
allogeneic hema...
18 Years - 70 YearsMasonic Cancer Center, University of Minnesota
Amifostine in Treating Patients With Myelodysplastic SyndromeNCT00003048
Myelodysplastic...
Amifostine Trih...
18 Years - M.D. Anderson Cancer Center
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaNCT00398138
Leukemia
Lung Cancer
Malignant Mesot...
Myelodysplastic...
Primary Periton...
WT-1 analog pep...
incomplete Freu...
sargramostim
polymerase chai...
flow cytometry
immunoenzyme te...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic SyndromeNCT00024050
Leukemia
Myelodysplastic...
busulfan
cyclophosphamid...
cyclosporine
methotrexate
allogeneic bone...
peripheral bloo...
- 65 YearsFred Hutchinson Cancer Center
Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesNCT00008177
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Chronic Myelomo...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Cyto...
Secondary Myelo...
Untreated Adult...
iodine I 131 mo...
total-body irra...
allogeneic hema...
peripheral bloo...
fludarabine pho...
cyclosporine
mycophenolate m...
laboratory biom...
50 Years - Fred Hutchinson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: